TMC
EW icon

Trellus Management Company’s Edwards Lifesciences EW Stock Holding History

Trellus Management Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-45,000
Closed -$1.41M – 70
2016
Q4 		$1.41M Buy
45,000
+21,900
+95% +$710K 2.07% 9
2016
Q3 		$928K Buy
+23,100
New +$870K 1.34% 16
2014
Q2 		– Sell
-30,000
Closed -$371K – 124
2014
Q1 		$371K Buy
+30,000
New +$346K 0.33% 70

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Trellus Management Company's EW Position: Q1 2017 in Review

Trellus Management Company sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 45,000 shares — an estimated $1.41M sold.

Trellus Management Company first reported a position in EW in Q1 2014 and held it in 3 quarters. The position peaked at $1.41M in Q4 2016. 690 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Trellus Management Company reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • Trellus Management Company sold 45,000 Edwards Lifesciences shares in Q1 2017, an estimated $1.41M.
  • Trellus Management Company first reported a position in Edwards Lifesciences in Q1 2014 and held it in 3 quarters.
  • Trellus Management Company's Edwards Lifesciences position peaked at $1.41M in Q4 2016.
  • 690 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Trellus Management Company's 13F filing for Q1 2017, filed 1 May 2017.